Filter posts

An Insider’s View of the BioGENEius Challenge

By Erica Hiar, Environics A big highlight every year for many attendees at BIO International …

Phase III Assets in High Demand - Results from the Business Forum Meeting Activity

At the BIO International Convention in Boston today, we released our results from the Business Forum …

What’s the Buzz?

Meet Deuteria Pharmaceuticals, winner of the 2012 Buzz of BIO competition. What is Buzz of …

We Are BIO

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you …

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the …

Prior User Rights and Trade Secrets

By Joe Allen, President, Allen and Associates One theme of the day is the cloud …

BIO Official Blogger Roundup

Want to know what’s happening at the 2012 BIO International Convention? Find out from our …

Recent Developments in Patentability: Prometheus and Myriad

By Joe Allen, President, Allen and Associates Recent Developments in Patentability: Prometheus and Myriad at …

BIO Official Blogger Roundup

Want to know what’s happening at the 2012 BIO International Convention? Find out from our …

From Bench to Bedside in a Bioeconomy

By Joe Allen, President, Allen and Associates It’s a sign of a well crafted program …